奥泰生物：2025年净利润同比减少27.83%

Core Insights - The company reported a revenue of 911 million yuan for the fiscal year 2025, representing a year-on-year growth of 5.16% [1] - The net profit attributable to shareholders decreased to 218 million yuan, reflecting a year-on-year decline of 27.83% [1] - The basic earnings per share (EPS) fell to 2.75 yuan, down 28.01% compared to the previous year [1]